The global stem cell market size is expected to grow from $11.59 billion in 2021 to $12.72 billion in 2022 at a compound annual growth rate (CAGR) of 9.8%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The stem cell market is expected to reach $18.51 billion in 2026 at a CAGR of 9.8%.
What is the Global Stem Cell Market?
The stem cell market consists of sales of stem cells products such as human embryonic stem cell, induced pluripotent stem cell and adult stem cell. Stem cells are the autologous or allogenic cells that can grow into many types of cells in in-vivo and in-vitro environment. Stem cells therapy is designed to aid physician in performing medical treatment of neurodegenerative diseases, diabetes and heart disease.
Get a Sample of the global stem cell market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2584&type=smp
What drives the Global Stem Cell Market?
There is an increase in the prevalence of chronic diseases worldwide which drives the stem cell market. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Currently, widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. According to WHO, in 2020, prevalence of chronic disease increased to 57%. As the prevalence of chronic disease increases, people opting for the stem cell-based treatment will rise, thus driving the market going forward. Currently, approximately 26,000 patients are treated with blood stem cells in Europe each year.
Get the full global stem cell industry report here:
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Global Stem Cell Market Segments
The global stem cell market is segmented:
By Source: Autologous, Allogeneic
By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Others
By Application: Regenerative Medicine, Drug Discovery and Development
By Geography: The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Stem Cell Global Market Report 2022provides market size and growth forecasts for the global stem cell market, global stem cell market share, stem cell market segments and geographies, stem cell market competitive landscape including leading competitors’ revenues, profiles and market shares. The stem cell market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Stem Cell Industry Playersinclude Anterogen Co., Ltd, Mesoblast Ltd, Osiris TherapeuticsInc, AlloSource, Cellular Engineering Technologies, BIOTIMEInc, Astellas Pharma USInc, Vericel, RTI SurgicalInc and Takara Bio Company. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
